13D/13G Filings - Euclidean Capital LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
07:17 am
Sale
2021-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
Euclidean Capital LLC 2,336,909
5.100%
-118,290decrease
(-4.82%)
Filing
History
2021-10-18
3:50 pm
Sale
2021-10-15 13G PMV Pharmaceuticals, Inc.
PMVP
Euclidean Capital LLC 2,455,199
5.400%
-2,218,624decrease
(-47.47%)
Filing
History
2021-05-07
5:00 pm
Purchase
2021-04-28 13G PMV Pharmaceuticals, Inc.
PMVP
Euclidean Capital LLC 4,673,823
10.400%
494,407increase
(+11.83%)
Filing
History
2021-02-12
4:00 pm
Purchase
2020-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
Euclidean Capital LLC 4,179,416
9.300%
4,179,416increase
(New Position)
Filing
History